In a quiet coastal town, industrial waste slowly contaminated the surrounding waters with toxic chemicals. Over time, residents began developing a mysterious illness that had never been seen before.

A virus plaguing shrimp and other seafood might also be responsible for an emerging eye disease in people that can cause permanent blindness, recent research suggests. Scientists in China have linked ...

A virus that typically infects marine animals, such as shrimp and fish, has jumped to humans and is causing chronic eye disease in some people, according to a study published in the journal Nature ...

Abstract: Monitoring of fish health through precise disease detection is essential in sustainable aquaculture management. In this article, a deep learning method is proposed to detect and classify ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Years lived with disability due to age-related eye ...

Before and after screenshots – Videos by @thebettaboys on Instagram A woman who’s spent 15 years raising beautiful betta fish shared a heartwarming story about her latest family member: Stevie, who ...

Abstract: The temperature, pH, dissolved oxygen, ammonia, and turbidity are environmental factors that are essential to the wellbeing of the aquaculture systems. Early detection of diseases during ...

This video shows wild betta fish surviving in a puddle, highlighting their resilience in harsh conditions. The situation raises questions about survival and adaptation. Starmer says he's 'fed up' with ...

Immunovant’s first-generation FcRn inhibitor flunked a pair of phase 3 eye disease trials, appearing to end the last hopes of commercializing the drug. The company set out plans back in 2022 to assess ...

Novo Nordisk weight loss drug Wegovy was recommended by England's drug price regulator to prevent heart attacks and strokes. The new recommendation from NICE will significantly expand access to Wegovy ...

March 30 (Reuters) - Viridian Therapeutics (VRDN.O), opens new tab shares slumped 34% to an eight-month low on Monday after its experimental treatment for thyroid eye disease lagged ‌rivals in ...